Beginners typically start at 300mcg to assess tolerance and response
Pharmaceutical intermediate synthesis
Subcutaneous injection is the most common research-context format today, but no published human pharmacokinetic study has formally characterized subcutaneous AOD-9604 (this gap was specifically called out in FDA's December 2024 review)
Patients are encouraged to maintain open communication with their GP, bariatric nurse, and dietitian, and to attend follow-up appointments consistently
Based on those results, your provider will confirm whether to proceed with the next cycle as-is, adjust the dose, or add or remove companion peptides
If you have questions about our Vitamin B-12 injections or would like to explore this service further, please visit one of our convenient locations